3 unknown. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Measles: new trials by email Literature Review of Measles trials Research Report on Measles
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings Licenced Measles-Rubella vaccine - Measles | Phase 2 | Unknown | University of Oxford | 450 | 2023-11-15 | 2024-10-31 |
| Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants Trivivac vaccine - Immunogenicity, Reactogenicity | Phase 2 / Phase 3 | Unknown | Queen Sirikit National Institute of Child Health | 200 | 2012-09-01 | 2013-01-08 |
| Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer attenuated measles vaccine - Non-Small Cell Lung Cancer, Measles | Phase 1 / Phase 2 | Unknown | Soroka University Medical Center | 15 | 2009-03-01 | 2009-01-23 |
Carcinoma, Non-Small-Cell Lung (1) · Rubella (1)
Infections (3) · Mononegavirales Infections (3) · Morbillivirus Infections (3) · Paramyxoviridae Infections (3) · RNA Virus Infections (3) · Virus Diseases (3) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Rubivirus Infections (1)
Queen Sirikit National Institute of Child Health (1) · Soroka University Medical Center (1) · University of Oxford (1)
Israel (1) · Thailand (1) · Uganda (1)